Recombinant Mouse Transforming Growth Factor, Beta Receptor II

• Cat.No.: Tgfbr2-1778M

Specification

• Cat. No.: Tgfbr2-1778M
• Description: Transforming growth factor beta type II (TGFbeta RII) is a key inhibitor of epithelial cell growth and tumor suppressor gene. It also regulate cell differentiation and has critical regulatory roles in the process of tissue repair and remodeling. TGF beta RII plays an important role as a tumor suppressor in non-small cell lung cancer (NSCLC) carcinogenesis.
• Source: Mammalian cells
• Molecular Weight: The predicted molecular weight of Recombinant Mouse TGF-β RII is Mr 44.6 kDa. However, the actual molecular weight as observed by migration on SDS Page is Mr 60-65 kDa.
• State Of Matter: Lyophilized.
• Purity: >95% by SDS Page and analyzed by silver stain.
• Endotoxin: <1.0 EU/µg as determined by the LAL method.
• Storage And Stability: This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
• Tag: Non

Gene Information

• Gene Name: Tgfbr2 transforming growth factor, beta receptor II [ Mus musculus ]
• Synonyms: Tgfbr2; transforming growth factor, beta receptor II; DNIIR; RIIDN; TBR-II; AU042018; TbetaRII; TbetaR-II; 1110020H15Rik
• Gene ID: 21813
• mRNA Refseq: NM_009371
• Protein Refseq: NP_033397
• UniProt ID: Q62312
• Chromosome Location: 9 F3; 9 69.0 cM
• Pathway: Adherens junction; Chronic myeloid leukemia; Colorectal cancer; Cytokine-cytokine receptor interaction; Endocytosis; MAPK signaling pathway; Pancreatic cancer; TGF-beta signaling pathway
• Function: ATP binding; SMAD binding; kinase activity; manganese ion binding; nucleotide binding; metal ion binding; protein serine/threonine kinase activity; protein kinase activity; receptor signaling protein serine/threonine kinase activity; transferase activity; transforming growth factor beta receptor activity, type II

Reviews

04/14/2023

TGFBR2 protein's remarkable performance in ELISA and protein electron microscopy structure analysis positions it as a valuable tool in various fields, including cardiovascular research, developmental biology, and molecular medicine.

12/13/2022

TGFBR2 protein's utility extends to protein electron microscopy structure analysis, where it plays a crucial role in investigating the detailed architecture and conformational changes of proteins.

06/25/2021

TGFBR2 protein is highly recommended for use in various research applications, including ELISA and protein electron microscopy structure analysis.

Q&As

How is TGFBR2 linked to autoimmune diseases?

Dysregulation of TGF-beta signaling, including TGFBR2, has been associated with autoimmune diseases. Understanding these pathways may provide insights into developing targeted therapies.

Are there clinical trials targeting TGFBR2?

Yes, there are ongoing clinical trials exploring the modulation of TGFBR2 for various conditions, including cancer and fibrotic diseases.

How does TGFBR2 affect cardiovascular health?

TGFBR2 is involved in cardiovascular development and homeostasis. Dysregulation can contribute to conditions like aortic aneurysms and other cardiovascular diseases.

Is TGFBR2 involved in neurological disorders?

Some studies suggest a potential link between TGFBR2 and neurological disorders. Further research is ongoing to understand its role in conditions like Alzheimer's and Parkinson's disease.

Can TGFBR2 be a therapeutic target for fibrotic diseases?

Yes, TGFBR2 is implicated in fibrosis, and targeting it may offer therapeutic options for diseases characterized by excessive tissue scarring.